Compare EVH & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVH | AOMR |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Real Estate Investment Trusts |
| Sector | Consumer Discretionary | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 272.4M | 218.7M |
| IPO Year | 2015 | 2019 |
| Metric | EVH | AOMR |
|---|---|---|
| Price | $3.46 | $9.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 3 |
| Target Price | $7.93 | ★ $11.08 |
| AVG Volume (30 Days) | ★ 2.8M | 57.2K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 14.07% |
| EPS Growth | N/A | ★ 53.85 |
| EPS | N/A | ★ 1.80 |
| Revenue | ★ $907,957,000.00 | N/A |
| Revenue This Year | $33.89 | N/A |
| Revenue Next Year | $15.84 | $1.38 |
| P/E Ratio | ★ N/A | $5.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.10 | $7.96 |
| 52 Week High | $11.92 | $10.21 |
| Indicator | EVH | AOMR |
|---|---|---|
| Relative Strength Index (RSI) | 66.67 | 65.75 |
| Support Level | $2.53 | $8.64 |
| Resistance Level | $4.20 | $9.22 |
| Average True Range (ATR) | 0.28 | 0.17 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 84.00 | 92.77 |
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.